Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Building trust and battling barriers : the urgent need to overcome vaccine hesitancy : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, July 1, 2021
| Building trust and battling barriers : the urgent need to overcome vaccine hesitancy : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, July 1, 2021 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2021 |
| Descrizione fisica | 1 online resource (iv, 29 pages) |
| Soggetto topico |
COVID-19 (Disease) - Vaccination - United States
Vaccine hesitancy - United States COVID-19 (Disease) - United States - Prevention COVID-19 (Disease) - Prevention COVID-19 (Disease) - Vaccination Vaccine hesitancy |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Building Trust and Battling Barriers |
| Record Nr. | UNINA-9910717481903321 |
| Washington : , : U.S. Government Publishing Office, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Celebrating Thanksgiving: consider other Thanksgiving activities
| Celebrating Thanksgiving: consider other Thanksgiving activities |
| Pubbl/distr/stampa | [Atlanta, Ga.] : , : Department of Health & Human Services - USA, CDC, , 2020 |
| Descrizione fisica | 1 online resource (1 unnumbered page) : color illustrations |
| Soggetto topico |
Thanksgiving Day
COVID-19 (Disease) - Prevention Social distancing (Public health) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Celebrating Thanksgiving |
| Record Nr. | UNINA-9910715036703321 |
| [Atlanta, Ga.] : , : Department of Health & Human Services - USA, CDC, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Challenges and opportunities of mRNA vaccines against SARS-CoV-2 : a multidisciplinary perspective / / Siguna Mueller
| Challenges and opportunities of mRNA vaccines against SARS-CoV-2 : a multidisciplinary perspective / / Siguna Mueller |
| Autore | Mueller Siguna |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2023] |
| Descrizione fisica | 1 online resource (460 pages) |
| Disciplina | 362.1962414 |
| Soggetto topico |
COVID-19 (Disease) - Prevention
COVID-19 vaccines |
| ISBN |
9783031189036
9783031189029 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Introduction -- Part I: Scientifi Underpinnings, early expectations, and emerging challenges from the global inoculation experience -- Chapter 2: Appraisal of Some of the Key Postulates Underlying mRNA Vaccines -- Chapter 3: Relevance for mRNA vaccine safety -- Chapter 4: From Challenges to Opportunities and Open Questions -- Chapter 5: The challenge of evaluating vaccine safety and effectiveness -- Chapter 6: Safeguarding against the analog of antimicrobial-resistance development -- Chapter 7: Scales, pseudoscales, the human factor, and a way forward -- Part II: A deeper dive into mRNA vaccine safety and security, and developments until Delta -- Chapter 8: mRNA Vaccine safety and efficacy - official criteria when AEs are caused by the injection -- Chapter 9: mRNA Covid-19 vaccines best reflect effective pharmaceuticals - basic considerations and LNPs -- Chapter 10: mRNA Covid-19 pharmaceuticals and the spike antigen -- Chapter 11: Other facets of SARS-CoV-2 immunity, the risk of immune tolerance and T cell exhaustion -- Part III: The Omicron variants -- Chapter 12: Omicron -- Chapter 13: Conclusion. |
| Record Nr. | UNINA-9910640386603321 |
Mueller Siguna
|
||
| Cham, Switzerland : , : Springer, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Contact tracing apps
| Contact tracing apps |
| Pubbl/distr/stampa | [Washington, D.C.] : , : GAO - Science, Technology Assessment, and Analytics, , 2020 |
| Descrizione fisica | 1 online resource (2 pages) : color illustrations |
| Collana | Science & tech spotlight |
| Soggetto topico |
COVID-19 (Disease) - Prevention
COVID-19 (Disease) - Transmission Contact tracing (Epidemiology) Public health surveillance Smartphones |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910713765703321 |
| [Washington, D.C.] : , : GAO - Science, Technology Assessment, and Analytics, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Coronavirus disease 2019 (COVID-19) : a clinical guide / / Ali Gholamrezanezhad and Michael P. Dube
| Coronavirus disease 2019 (COVID-19) : a clinical guide / / Ali Gholamrezanezhad and Michael P. Dube |
| Autore | Gholamrezanezhad Ali |
| Pubbl/distr/stampa | Hoboken, NJ : , : John Wiley & Sons, Inc., , [2023] |
| Descrizione fisica | 1 online resource (701 pages) |
| Disciplina | 362.1962414 |
| Soggetto topico |
COVID-19 (Disease)
COVID-19 (Disease) - Prevention |
| ISBN |
1-119-78974-5
1-119-78972-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- Chapter 1 COVID-19: Epidemiology -- Origin -- Animal Host -- Infectivity and Incubation -- Modes of Transmission -- Overview -- Respiratory Droplets -- Aerosolization -- Direct Surface Contact and Fomites -- Fecal-Oral -- Bloodborne -- Semen and Vaginal Secretions -- Asymptomatic Transmission -- Virulence and Mortality -- Case Fatality Rate -- Serial Interval -- Reproduction Number/Reproduction Ratio -- Excess Mortality -- Demographics -- Overview -- Age -- Sex -- Race and Ethnicity -- Disease Prevention -- Vaccinations -- Personal Protective Equipment: Respirators and Masks -- Physical Distancing -- Hand and Surface Sanitation -- Adequate Ventilation of Indoor Spaces -- Use of Outdoor Spaces -- Global Impacts -- Distribution -- International Response -- Future Outbreaks -- Conclusions -- References -- Chapter 2 COVID-19: Virology -- Coronaviruses -- Taxonomy -- Morphology -- Nucleic Acid -- Antigenicity -- SARS-CoV-2 -- Morphology and Nucleic Acid -- Spike Protein -- Origin -- Viral Transmission -- Variants -- References -- Chapter 3 COVID-19: Laboratory/Serologic Diagnostics -- Molecular Diagnostics for COVID-19 -- Nucleic Acid Amplification Testing -- RT-qPCR -- RT-LAMP -- CRISPR-Based Techniques -- Sequencing Techniques -- Antigen Testing -- Viral Culture -- Antibody Testing for COVID-19 -- Principles of Antibody Testing -- Antibody Assays for SARS-CoV-2 -- Assay Target Selection -- Binding Assays -- Neutralization Assays -- Antibody Assay Sensitivity and Specificity -- Humoral Response to SARS-CoV-2 Infection -- Kinetics of Antibody Response -- Antibody Response and Disease Severity -- Duration of Immunity -- Current and Potential Applications of Antibody-Based Tests in SARS-CoV-2 -- Management of Individual Disease and Sequelae Monitoring.
Contact Tracing -- Vaccine Efficacy -- Conclusions and Future Directions -- References -- Chapter 4 COVID-19: Radiologic Diagnosis -- Current Guidelines on When to Image -- Fleischner Society -- World Health Organization -- Practical Points -- Technical Considerations to Limit Spread While Imaging -- Chest Radiography -- Cross-Sectional Imaging -- Ultrasound -- Imaging by Modality -- X-Ray -- Computed Tomography -- Ultrasound -- PET -- MRI -- Guidelines for Reporting -- RSNA -- COVID-19 Reporting and Data System -- COVID-19 Imaging Reporting and Data System -- References -- Chapter 5 COVID-19: Pathology Perspective -- Gross and Histopathologic Findings in the Respiratory System -- Gross and Histopathologic Findings in the Cardiovascular System -- Histopathologic Findings in Kidney -- Histopathologic Findings in the Gastrointestinal Tract and Liver -- Histopathologic Findings in Brain -- Histopathologic Findings in Skin -- References -- Chapter 6 COVID-19: Immunology -- Anatomic Progression of COVID-19 -- Adaptive Immune Response in the Nasal Passages and the Lungs -- Immune Response to Immunization -- Immune Correlates of Protection from Infection -- Decline in Vaccine-Induced Immune Responses over Time -- Immune Consequences of Virologic Dissemination -- Autoantibodies Against Type I IFN -- Viral Evasion -- Immune Dysregulation -- Antibody-Dependent Cellular Cytotoxicity -- Cytokine Storm -- Conclusions -- Acknowledgments -- References -- Chapter 7 COVID-19: Presentation and Symptomatology -- Pulmonary Manifestations of COVID-19 -- Atypical Acute Respiratory Distress Syndrome -- Otolaryngologic Manifestations of COVID-19 -- Sense of Smell -- Voice Disorders -- Hearing, Tinnitus, and Facial Nerve -- Gastrointestinal Manifestation of COVID-19 -- Coronavirus and Pregnancy -- Physiologic Changes and Effect of SARS-CoV-2 Infection. General Symptoms of COVID-19 in Obstetric Patients -- Impact of COVID-19 on Gestation: Maternal and Neonatal Outcomes -- Vertical Transmission and Possible Fetal Complications -- COVID-19 and Delivery -- Breastfeeding -- Vaccination -- Urologic Manifestations of COVID-19 -- Kidneys -- Genital and Lower Urinary Tract Infection -- Disorders of Genital Organ Function -- Infertility -- References -- Chapter 8 COVID-19: Risk Stratification -- Potential Biomarkers for COVID-19 Detection, Severity, and Mortality -- Host Risk Factors for COVID-19 -- ABO Blood Type as an Additional Risk Factor -- ABO Blood Group and Rh Factor -- Association of Blood Group with Viral Respiratory Diseases -- Association of Blood Type with Higher Susceptibility to COVID-19 Infection and Outcomes -- Genetic Association and Underlying Molecular Mechanisms -- ML Methods for X-Ray and CT Image Classification and Prediction -- References -- Chapter 9 COVID-19: Outpatient Management in Adults -- Potential Conflicts of Interest -- Initial Diagnosis -- Prognosis and Choice of Admission Versus Outpatient Management -- Home Monitoring -- Telehealth Diagnosis and Follow-up -- Pulse Oximetry Monitoring -- Post-Hospital Discharge Care -- General Management Issues -- Isolation -- Hydration and Nutrition -- Continuation of Ongoing Therapies -- Nutritional Supplements -- Anticoagulation -- Use of Home Supplemental Oxygen -- Antivirals and Anti-inflammatory Treatments -- Anti-SARS-CoV-2 mAbs -- Selection of Outpatients to Receive Anti-SARS-CoV-2 mAbs -- Bamlanivimab Plus Etesevimab -- Casirivimab Plus Imdevimab -- Sotrovimab -- Bebtelovimab -- Side Effects of Anti-SARS-CoV-2 mAbs -- Distribution of mAbs -- Oral Antivirals -- Molnupiravir -- Nirmatrelvir (PF-07321332)/Ritonavir -- Outpatient Anti-inflammatory Interventions -- Inhaled Budesonide -- Fluvoxamine -- Dexamethasone. Drugs That Are Not Recommended for Outpatient Use -- Janus Kinase Inhibitors/Anti-IL-6 Therapies -- Chloroquine and Hydroxychloroquine -- Ivermectin -- Azithromycin -- Lopinavir/Ritonavir -- Convalescent Plasma -- Colchicine -- Summary -- References -- Chapter 10 COVID-19: Inpatient Management -- Respiratory Support for Hospitalized Patients with COVID-19 -- Noninvasive Respiratory Support -- Prone Positioning in Awake Patients -- Caring for the Critically Ill Patient with COVID-19 -- Practical Considerations for Intubating Patients -- Mechanical Ventilation of Patients with COVID-19 -- Rescue Therapies for Refractory Hypoxemia of Ventilated Patients -- Pharmacologic Therapies for Hospitalized Patients with COVID-19 -- Use of Antivirals in Patients Hospitalized for COVID-19 -- Anti-inflammatory Therapies for Hospitalized Patients with COVID-19 -- Therapies that Have No Benefit in Hospitalized Patients with COVID-19 -- Extrapulmonary Disease in Acutely Ill Patients with COVID-19 -- Thromboembolic Disease -- Cardiac Complications -- Renal Complications -- Infectious Complications -- Performing Aerosol-Generating Procedures in Patients with COVID-19 -- Bronchoscopy in COVID-19 -- Tracheostomy in Patients with COVID-19 -- Cardiopulmonary Resuscitation of the Patient with COVID-19 -- Coordinating Patient Placement and Care in COVID-19 Units -- Increasing ICU Capacity -- Additional Management Considerations -- References -- Chapter 11 COVID-19: ICU and Critical Care Management -- Epidemiology of Critically Ill Patients with COVID-19 Pneumonia -- Risk Factors for Severe Disease -- Mortality -- Infection Prevention and Control of COVID-19 in the ICU -- Aerosol-Generating Procedures -- Visitation -- Cardiopulmonary Resuscitation in COVID-19 -- Hemodynamic Support in COVID-19 -- Management of Respiratory Failure from COVID-19 -- Intubation. Ventilator Management -- Prone Positioning -- Treatment of COVID-19-Associated ARDS with Corticosteroids -- Tocilizumab for Critical COVID-19 Illness -- Extracorporeal Membrane Oxygenation for COVID-19 ARDS -- Venous Thromboembolism and Anticoagulation in COVID-19 -- After the ICU: Challenges for Survivors of COVID-19 Critical Illness -- References -- Chapter 12 COVID-19 in Pediatrics -- Epidemiology -- Epidemiology of Multisystem Inflammatory Syndrome in Children -- Transmission in Children -- Neonatal Transmission -- Breastfeeding -- Clinical Manifestations -- Disease Severity -- Infection in Infants (Age < -- 1 Year) -- Cutaneous Manifestations -- COVID Toes -- Neurologic Symptoms -- Atypical Clinical Manifestations -- Imaging Findings -- MIS-C Clinical Manifestations -- Post-Acute Sequelae of SARS-CoV-2 (PASC) in Children -- Approach to Diagnosis -- Screening and Diagnosis in Symptomatic Patients -- Screening and Diagnosis in Asymptomatic Patients -- Neonatal Testing -- COVID-Recovered Patients -- Retesting of COVID-Recovered Patients -- Testing of COVID-19 Fully Vaccinated Persons -- MIS-C Diagnosis -- Hyperinflammation in COVID-19 Versus MIS-C -- Management -- Outpatient Management -- Inpatient Management -- Special Populations -- Antiviral Therapy -- Glucocorticoids -- Nonsteroidal Anti-inflammatory Drugs -- Convalescent Plasma -- Adjunctive Therapy -- Kinase Inhibitors -- Superimposed Infections -- Management of MIS-C -- Guidance for Return to Sports After SARS-CoV-2 Infection -- Vaccines -- References -- Chapter 13 Pharmacologic Therapeutics for COVID-19 -- Virus Life Cycle -- Drug Development for SARS-CoV-2 -- Immune Responses that Contribute to COVID-19 Pathology -- Challenges to Discover and Deploy Drugs for a New Infectious Agent -- Therapeutic Classes -- Antivirals -- Camostat (Foipan) -- Nafamostat -- Upamostat. Chloroquine and Hydroxychloroquine. |
| Record Nr. | UNINA-9910829981303321 |
|
Gholamrezanezhad Ali
|
||
| Hoboken, NJ : , : John Wiley & Sons, Inc., , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Coronavirus Politics : The Comparative Politics and Policy of COVID-19 / / Scott L. Greer, Elizabeth J. King, André Peralta-Santos, and Elize Massard da Fonseca, editors
| Coronavirus Politics : The Comparative Politics and Policy of COVID-19 / / Scott L. Greer, Elizabeth J. King, André Peralta-Santos, and Elize Massard da Fonseca, editors |
| Autore | Greer Scott L |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | University of Michigan Press |
| Descrizione fisica | 1 online resource (1 online resource viii, 649 pages) : illustrations |
| Disciplina | 362.1962/414 |
| Soggetto topico |
COVID-19 (Disease) - Prevention
COVID-19 (Disease) - Government policy COVID-19 (Disease) - Political aspects |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-472-03862-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Contents -- Part I -- 1. Introduction: Explaining Pandemic Response / Scott L. Greer, Elizabeth J. King, and Elize Massard da Fonseca -- 2. Playing Politics: The World Health Organization's Response to COVID-19 / Matthew M. Kavanagh, Renu Singh, and Mara Pillinger -- 3. State Responses to the COVID-19 Pandemic: Governance, Surveillance, Coercion, and Social Policy / Holly Jarman -- Part II. Asia -- 4. China's Leninist Response to COVID-19: From Information Repression to Total Mobilization / Victor C. Shih -- 5. Public Policy and Learning from SARS: Explaining COVID-19 in Hong Kong / John P. Burns -- 6. Institutions Matter in Fighting COVID-19: Public Health, Social Policies, and the Control Tower in South Korea / June Park -- 7. Unified, Preventive, Low-cost Government Response to COVID-19 in Việt Nam / Emma Willoughby -- 8. Fighting COVID-19 in Japan: A Success Story? / Takashi Nagata, Akihito Hagihara, Alan Kawarai Lefor, Ryozo Matsuda, and Monika Steffen -- 9. Singapore's Response to COVID-19: An Explosion of Cases despite Being a "Gold Standard" / Rebecca Wai -- 10. India's Response to COVID-19 / Minakshi Raj -- 11. COVID-19 Response in Central Asia: A Cautionary Tale / Pauline Jones and Elizabeth J. King -- Part III. Europe -- 12. COVID-19 in the United Kingdom: How Austerity and a Loss of State Capacity Undermined the Crisis Response / Gemma A. Williams, Selina Rajan, and Jonathan D. Cylus -- 13. The European Union Confronts COVID-19: Another European Rescue of the Nation-state? / Eleanor Brooks, Anniek de Ruijter, and Scott L. Greer -- 14. Denmark's Response to COVID-19: A Participatory Approach to Policy Innovation / Darius Ornston -- 15. France's Multidimensional COVID-19 Response: Ad Hoc Committees and the Sidelining of Public Health Agencies / Sarah D. Rozenblum.
16. Political Resonance in Austria's Coronavirus Crisis Management / Margitta Mätzke -- 17. Three Approaches to Handling the COVID Crisis in Federal Countries: Germany, Austria, and Switzerland / Thomas Czypionka and Miriam Reiss -- 18. Italy's Response to COVID-19 / Michelle Falkenbach and Manuela Caiani -- 19. Spain's Response to COVID-19 / Kenneth A. Dubin -- 20. A Tale of Two Pandemics in Three Countries: Portugal, Spain, and Italy / André Peralta-Santos, Luis Saboga-Nunes, and Pedro C. Magalhães -- 21. Greece at the Time of COVID-19: Caught between Scylla and Charybdis / Elena Petelos, Dimitra Lingri, and Christos Lionis -- 22. COVID-19 in Turkey: Public Health Centralism / Saime Özçürümez -- 23. COVID-19 in Central and Eastern Europe: Focus on Czechia, Hungary, and Bulgaria / Olga Löblová, Julia Rone, and Endre Borbáth -- 24. COVID-19 in the Russian Federation: Government Control during the Epidemic / Elizabeth J. King and Victoria I. Dudina -- Part IV. Americas -- 25. The Politics and Policy of Canada's COVID-19 Response / Patrick Fafard, Adèle Cassola, Margaret MacAulay, and Michèle Palkovits -- 26. Anatomy of a Failure: COVID-19 in the United States / Phillip M. Singer, Charley E. Willison, N'dea Moore-Petinak, and Scott L. Greer -- 27. COVID-19 in Brazil: Presidential Denialism and the Subnational Government's Response / Elize Massard da Fonseca, Nicoli Nattrass, Luísa Bolaffi Arantes, and Francisco Inácio Bastos -- 28. Colombia's Response to COVID-19: Pragmatic Command, Social Contention, and Political Challenges / Claudia Acosta, Mónica Uribe-Gómez, and Durfari Velandia-Naranjo -- 29. The Politics of the COVID-19 Pandemic Response in Chile / Claudio A. Méndez -- Part V. Africa -- 30. Pandemic amid Political Crisis: Malawi's Experience with and Response to COVID-19 / Kim Yi Dionne, Boniface Dulani, and Sara E. Fischer. 31. Adapting COVID-19 Containment in Africa: Lessons from Tanzania / Thespina (Nina) Yamanis, Ruth Carlitz, and Henry A. Mollel -- 32. Confronting Legacies and Charting a New Course?: The Politics of Coronavirus Response in South Africa / Joseph Harris -- 33. Comparative Analysis of COVID-19 Transmission and Mortality in Select African Countries / Kanayo K. Ogujiuba and Uviwe Binase -- 34. Conclusion / Scott L. Greer, Elize Massard da Fonesca, and Elizabeth J. King -- Contributors -- Index. |
| Record Nr. | UNINA-9910468224003321 |
|
Greer Scott L
|
||
| University of Michigan Press | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19
| COVID-19 |
| Autore | Mittal Neeraj |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Sharjah : , : Bentham Science Publishers, , 2021 |
| Descrizione fisica | 1 online resource (223 pages) |
| Disciplina | 616.2414 |
| Altri autori (Persone) |
BhadadaSanjay K
KatareO. P |
| Soggetto topico |
COVID-19 (Disease) - Prevention
COVID-19 (Disease) - Economic aspects COVID-19 (Disease) - Social aspects COVID-19 Pandemic, 2020- |
| Soggetto non controllato |
Communicable Diseases
Medical |
| ISBN | 1-68108-808-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Chapter 1 -- Sunishtha1, Govind Singh1 and Sanju Nanda1,* -- INTRODUCTION -- THE ATHENIAN PLAGUE -- PLAGUE OF JUSTINIAN -- THE BLACK DEATH -- SPANISH FLU -- AIDS -- SMALLPOX -- SARS -- SWINE FLU OR H1N1 PANDEMIC -- EBOLA -- COVID-19 -- ORIGIN OF CORONAVIRUS -- TYPES OF CORONAVIRUSES -- DISEASE ASSOCIATED WITH CORONAVIRUSES -- MURINE HEPATITIS VIRUS (MHV) -- Central Nervous System -- Hepatitis -- Pneumonitis -- BOVINE CORONAVIRUS -- HUMAN CORONAVIRUS -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 2 -- Hitesh Malhotra1,*, Anjoo Kamboj1 and Peeyush Kaushik1 -- INTRODUCTION -- GENOMIC STRUCTURE OF CORONAVIRUS -- STRUCTURAL PROTEINS -- Spike Protein -- Small Membrane Protein -- Membrane Protein -- Hemagglutinin-Esterase -- Nucleocapsid and Internal Proteins -- Replicase Protein -- VIRAL CYCLE -- OUTBREAKS OF CORONAVIRUS -- Porcine Coronavirus -- Avian Coronavirus -- Feline Coronavirus -- Bovine Coronavirus -- Murine Coronavirus -- Human Coronavirus -- SARS-CoV -- MERS-CoV -- COVID-19 -- Introduction -- Chronology of COVID-19 -- Symptoms -- Transmission -- Treatment -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 3 -- Kamya Goyal1,2,#, Shammy Jindal1,#, Tarun Kumar3, Jugnu Goyal4, Reena Sharma5, Ravinder Singh6 and Samir Mehndiratta7,8,* -- INTRODUCTION -- GEOGRAPHICAL DISTRIBUTION -- GLOBAL EPIDEMIOLOGY OF COVID-19 -- Effect of Age, Sex and other Factors on Covid-19-Related Deaths -- COVID-19 CASE COMPARISONS IN DIFFERENT REGION OF WORLD (WORLD HEALTH ORGANIZATION, 2020) -- COVID-19 IN INDIA -- REPORT BY ICMR ON COVID-19 ABOUT CONTAINMENT ZONE IN INDIA -- NATIONAL RESPONSES ON COVID-19 WORLDWIDE.
Asia -- China -- South Korea -- Middle Eastern -- Iran -- Europe -- Spain -- France -- North America -- United States -- South America -- Africa -- Oceania -- EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD -- THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19 -- OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY -- Herd Immunity-COVID-19 -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 -- Anirban Ghosh1 and Shamsher Singh1,* -- INTRODUCTION -- TRANSMISSION OF COV -- Virus Life Cycle -- Role of Structural Proteins in The Pathogenesis -- A. Spike Protein -- B. Hemagglutinin-Esterase (HE) Protein -- C. Membrane (M) Protein -- D. Small Envelop (E) Protein -- E. Nucleocapsid (N) Protein and Internal (I) Protein -- F. Replicase Proteins -- G. CoV Associated Protein -- Pathophysiology from a Cell Biology Perspective -- Phase I. Asymptomatic Stage (First 1-2 Days of Infection) -- Phase II. Upper Airway and Conducting Airway Response (Next Few Days) -- Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 5 -- Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,* -- INTRODUCTION -- CLINICAL PRESENTATIONS OF COVID-19 INFECTION -- INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19 -- Neonates or Newborns (Upto 1 Month) -- Infants (1 Month-2 Years), Children (2-10 Years) -- Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients -- Elderly (> -- 60 Years) and Older (> -- 80 Years) Patients -- ACE2 -- Gender -- Blood Group -- Previous Immunization -- COMORBIDITY -- CONCLUSION. LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 6 -- Richa Deshpande1,#, Aishwarya Joshi1,#, Nikunj Tandel1 and Rajeev K. Tyagi2,* -- COVID-19: A PANDEMIC DISEASE -- COVID-19: EARLY DETECTION BASED ON SYMPTOMS -- Clinical Analysis -- Hematological Analysis -- Chest CT -- COVID-19: MOLECULAR DETECTION OF VIRUS -- RT-PCR Based Assays -- Loop Mediated Isothermal Amplification (LAMP) -- CRISPR-Isothermal Amplification Based Assays -- Microarrays -- Metagenomic Sequencing Based Methods -- Gold Nanoparticles-Based Colorimetric Assay -- COVID-19: SERIOLOGICAL AND IMMUNOLOGICAL BASED DETECTION -- BIOMARKER IDENTIFICATION: APPROACH OF SEROLOGICAL PLATFORM -- Antibody Biomarkers -- Antigen Biomarkers -- Procalcitonin and Interleukin-6 as Prognostic COVID-19 Biomarkers -- SEROLOGICAL AND IMMUNOLOGICAL ASSAYS -- Enzyme-linked Immunosorbent Assay (ELISA) -- Lateral Flow Immunoassay -- Neutralization Assays -- Luminescence-based Immunoassays -- Biosensor Tests -- Rapid Antigen Tests -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index. |
| Altri titoli varianti | COVID-19 |
| Record Nr. | UNINA-9910794540303321 |
|
Mittal Neeraj
|
||
| Sharjah : , : Bentham Science Publishers, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19
| COVID-19 |
| Autore | Mittal Neeraj |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Sharjah : , : Bentham Science Publishers, , 2021 |
| Descrizione fisica | 1 online resource (223 pages) |
| Disciplina | 616.2414 |
| Altri autori (Persone) |
BhadadaSanjay K
KatareO. P |
| Soggetto topico |
COVID-19 (Disease) - Prevention
COVID-19 (Disease) - Economic aspects COVID-19 (Disease) - Social aspects COVID-19 Pandemic, 2020- |
| Soggetto non controllato |
Communicable Diseases
Medical |
| ISBN | 1-68108-808-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Chapter 1 -- Sunishtha1, Govind Singh1 and Sanju Nanda1,* -- INTRODUCTION -- THE ATHENIAN PLAGUE -- PLAGUE OF JUSTINIAN -- THE BLACK DEATH -- SPANISH FLU -- AIDS -- SMALLPOX -- SARS -- SWINE FLU OR H1N1 PANDEMIC -- EBOLA -- COVID-19 -- ORIGIN OF CORONAVIRUS -- TYPES OF CORONAVIRUSES -- DISEASE ASSOCIATED WITH CORONAVIRUSES -- MURINE HEPATITIS VIRUS (MHV) -- Central Nervous System -- Hepatitis -- Pneumonitis -- BOVINE CORONAVIRUS -- HUMAN CORONAVIRUS -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 2 -- Hitesh Malhotra1,*, Anjoo Kamboj1 and Peeyush Kaushik1 -- INTRODUCTION -- GENOMIC STRUCTURE OF CORONAVIRUS -- STRUCTURAL PROTEINS -- Spike Protein -- Small Membrane Protein -- Membrane Protein -- Hemagglutinin-Esterase -- Nucleocapsid and Internal Proteins -- Replicase Protein -- VIRAL CYCLE -- OUTBREAKS OF CORONAVIRUS -- Porcine Coronavirus -- Avian Coronavirus -- Feline Coronavirus -- Bovine Coronavirus -- Murine Coronavirus -- Human Coronavirus -- SARS-CoV -- MERS-CoV -- COVID-19 -- Introduction -- Chronology of COVID-19 -- Symptoms -- Transmission -- Treatment -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 3 -- Kamya Goyal1,2,#, Shammy Jindal1,#, Tarun Kumar3, Jugnu Goyal4, Reena Sharma5, Ravinder Singh6 and Samir Mehndiratta7,8,* -- INTRODUCTION -- GEOGRAPHICAL DISTRIBUTION -- GLOBAL EPIDEMIOLOGY OF COVID-19 -- Effect of Age, Sex and other Factors on Covid-19-Related Deaths -- COVID-19 CASE COMPARISONS IN DIFFERENT REGION OF WORLD (WORLD HEALTH ORGANIZATION, 2020) -- COVID-19 IN INDIA -- REPORT BY ICMR ON COVID-19 ABOUT CONTAINMENT ZONE IN INDIA -- NATIONAL RESPONSES ON COVID-19 WORLDWIDE.
Asia -- China -- South Korea -- Middle Eastern -- Iran -- Europe -- Spain -- France -- North America -- United States -- South America -- Africa -- Oceania -- EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD -- THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19 -- OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY -- Herd Immunity-COVID-19 -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 -- Anirban Ghosh1 and Shamsher Singh1,* -- INTRODUCTION -- TRANSMISSION OF COV -- Virus Life Cycle -- Role of Structural Proteins in The Pathogenesis -- A. Spike Protein -- B. Hemagglutinin-Esterase (HE) Protein -- C. Membrane (M) Protein -- D. Small Envelop (E) Protein -- E. Nucleocapsid (N) Protein and Internal (I) Protein -- F. Replicase Proteins -- G. CoV Associated Protein -- Pathophysiology from a Cell Biology Perspective -- Phase I. Asymptomatic Stage (First 1-2 Days of Infection) -- Phase II. Upper Airway and Conducting Airway Response (Next Few Days) -- Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 5 -- Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,* -- INTRODUCTION -- CLINICAL PRESENTATIONS OF COVID-19 INFECTION -- INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19 -- Neonates or Newborns (Upto 1 Month) -- Infants (1 Month-2 Years), Children (2-10 Years) -- Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients -- Elderly (> -- 60 Years) and Older (> -- 80 Years) Patients -- ACE2 -- Gender -- Blood Group -- Previous Immunization -- COMORBIDITY -- CONCLUSION. LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 6 -- Richa Deshpande1,#, Aishwarya Joshi1,#, Nikunj Tandel1 and Rajeev K. Tyagi2,* -- COVID-19: A PANDEMIC DISEASE -- COVID-19: EARLY DETECTION BASED ON SYMPTOMS -- Clinical Analysis -- Hematological Analysis -- Chest CT -- COVID-19: MOLECULAR DETECTION OF VIRUS -- RT-PCR Based Assays -- Loop Mediated Isothermal Amplification (LAMP) -- CRISPR-Isothermal Amplification Based Assays -- Microarrays -- Metagenomic Sequencing Based Methods -- Gold Nanoparticles-Based Colorimetric Assay -- COVID-19: SERIOLOGICAL AND IMMUNOLOGICAL BASED DETECTION -- BIOMARKER IDENTIFICATION: APPROACH OF SEROLOGICAL PLATFORM -- Antibody Biomarkers -- Antigen Biomarkers -- Procalcitonin and Interleukin-6 as Prognostic COVID-19 Biomarkers -- SEROLOGICAL AND IMMUNOLOGICAL ASSAYS -- Enzyme-linked Immunosorbent Assay (ELISA) -- Lateral Flow Immunoassay -- Neutralization Assays -- Luminescence-based Immunoassays -- Biosensor Tests -- Rapid Antigen Tests -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index. |
| Altri titoli varianti | COVID-19 |
| Record Nr. | UNINA-9910817553703321 |
|
Mittal Neeraj
|
||
| Sharjah : , : Bentham Science Publishers, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19 Vaccines : Current State and Perspectives / / by Ibrokhim Y. Abdurakhmonov, editor
| COVID-19 Vaccines : Current State and Perspectives / / by Ibrokhim Y. Abdurakhmonov, editor |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , 2023 |
| Descrizione fisica | 1 online resource (160 pages) |
| Disciplina | 362.1962414 |
| Soggetto topico |
COVID-19 (Disease) - Vaccination
COVID-19 (Disease) - Prevention |
| ISBN | 1-80355-358-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910678587303321 |
| [Place of publication not identified] : , : IntechOpen, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees
| COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees |
| Pubbl/distr/stampa | [Washington, D.C.] : , : United States Government Accountability Office, , 2021 |
| Descrizione fisica | 1 online resource (vii, 333 pages) : color illustrations |
| Soggetto topico |
COVID-19 (Disease) - Vaccination - United States - Planning
COVID-19 (Disease) - Economic aspects - United States COVID-19 (Disease) - Diagnosis - United States COVID-19 (Disease) - United States - Prevention COVID-19 (Disease) - Treatment - United States Vaccines industry - Government policy - United States Vaccines - Development - United States Public health administration - United States COVID-19 (Disease) - Diagnosis COVID-19 (Disease) - Economic aspects COVID-19 (Disease) - Prevention COVID-19 (Disease) - Treatment Expenditures, Public Public health administration Vaccines industry - Government policy |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | COVID-19 |
| Record Nr. | UNINA-9910715226403321 |
| [Washington, D.C.] : , : United States Government Accountability Office, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
